Nanoparticles of hydrophobized cluster dextrin as biodegradable drug carriers: solubilization and encapsulation of amphotericin B

被引:29
作者
Kaneo, Y. [1 ]
Taguchi, K. [1 ]
Tanaka, T. [1 ]
Yamamoto, S. [1 ]
机构
[1] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Lab Biopharmaceut, Fukuyama, Hiroshima 7290292, Japan
关键词
Cluster dextrin; Nanoparticle; Amphotericin B; Biodegradation; Biodisposition; BRANCHING ENZYME; CYCLIZATION REACTION; HEMOLYTIC-ACTIVITY; AGGREGATION STATE; PULLULAN; DELIVERY; WATER; POLYSACCHARIDES; MICELLES; BIODISPOSITION;
D O I
10.1016/S1773-2247(14)50072-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cluster dextrin (CDex), a highly branched cyclic dextrin, is a novel glucose polymer that is produced from a waxy corn starch by a branching enzyme. Despite its large molecular weight (462 kDa),CDex is highly water-soluble and is easily digested by enzymes, such as alpha-amylase. Amphotericin B (AmB) is a broad-spectrum fungicidal antibiotic used primarily in the treatment of life-threatening systemic fungal infections. Unfortunately. AmB is insoluble in water: therefore, we have attempted to render it soluble and transportable by encapsulating it in hydrophobized CDex nanoparticles. The amphiphilic polymers of CDex were prepared with hydrophobic groups bonded through ester bonds, and the degrees of substitution were 1.00 mol/mol % for n-octanoyl CDex, 1.80 mol/mol % for stearoyl CDex, 1.07 mol/mol % for oleoyl CDex, and 1.07 moll mol % for cholesteryl CDex. To study the formation of the monodispersed nanoparticles of the hydrophobized CDexs by self-assembly and their complex formations with AmB, size-exclusion chromatography and dynamic light scattering were utilized. AmB encapsulated in the cholesteryl CDex nanoparticle was found to be non-hemolytic, even at 30 mu g/mL, which suggested that it had a much higher concentration than the minimum inhibitory concentration of 0.78 mu g/mL required to inhibit Saccharomyces cerevisiae Therefore, the biodistributions of the AmB-loaded cholesteryl CDex nanoparticles and AmBisome (liposomal AmB) were further compared in mice. After intravenous injection of the AmB-loaded cholesteryl CDex nanoparticle, prolonged persistence of AmB in the circulating blood was observed.
引用
收藏
页码:344 / 351
页数:8
相关论文
共 44 条
[1]   Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles:: effects of acyl chain length [J].
Adams, ML ;
Kwon, GS .
JOURNAL OF CONTROLLED RELEASE, 2003, 87 (1-3) :23-32
[2]   Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin [J].
Akiyoshi, K ;
Kobayashi, S ;
Shichibe, S ;
Mix, D ;
Baudys, M ;
Kim, SW ;
Sunamoto, J .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) :313-320
[3]   SELF-AGGREGATES OF HYDROPHOBIZED POLYSACCHARIDES IN WATER - FORMATION AND CHARACTERISTICS OF NANOPARTICLES [J].
AKIYOSHI, K ;
DEGUCHI, S ;
MORIGUCHI, N ;
YAMAGUCHI, S ;
SUNAMOTO, J .
MACROMOLECULES, 1993, 26 (12) :3062-3068
[4]  
AN D.B., 1996, Polysaccharides in Medicinal Applications, P505
[5]   Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems [J].
Aumelas, A. ;
Serrero, A. ;
Durand, A. ;
Dellacherie, E. ;
Leonard, M. .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2007, 59 (01) :74-80
[6]   EFFECTS OF THE AGGREGATION STATE OF AMPHOTERICIN-B ON ITS TOXICITY TO MICE [J].
BARWICZ, J ;
CHRISTIAN, S ;
GRUDA, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) :2310-2315
[7]   Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate [J].
Bekersky, I ;
Fielding, RM ;
Dressler, DE ;
Lee, JW ;
Buell, DN ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :834-840
[8]   Carrier effects on biological activity of amphotericin B [J].
Brajtburg, J ;
Bolard, J .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (04) :512-+
[9]   DETERMINATION OF THE CRITICAL MICELLE CONCENTRATION OF SURFACTANTS USING THE FLUORESCENT-PROBE N-PHENYL-1-NAPHTHYLAMINE [J].
BRITO, RMM ;
VAZ, WLC .
ANALYTICAL BIOCHEMISTRY, 1986, 152 (02) :250-255
[10]  
Chakravarthi S. S., 2007, Nanoparticulate drug delivery systems, V166, P51, DOI DOI 10.1201/9781420008449-3